Trusted Regulatory Expertise
With over 25 years of experience in leading biopharmaceutical companies, our in-house experts possess extensive regulatory knowledge.
We provide strategic regulatory support for pharmaceuticals, medical devices and consumer health. Our experts deliver strategic regulatory guidance across complex development and registration pathways, helping clients navigate innovation with confidence and accelerate access to market.
Regulatory excellence drives successful business outcomes
We demonstrate strong expertise in navigating complex regulatory projects, delivering strategic solutions for
- New Chemical Entities (NCEs)
- Biologics License Applications (BLAs)
- Monoclonal Antibodies (mAbs)
- Antibody - Drug Conjugates (ADCs)
- Value- Added Medicines (VAMs)
across key therapeutic areas including oncology, rare diseases, precise medicine, neuroscience, virology, gastroenterology, and pain management.
ReneMed Strategic Regulatory Solutions
- Regulatory Strategy
- Regulatory Planning & Submission
- Regulatory Compliance
- Regulatory Mitigation Plan
- Regenerative Medicine
- Orphan Drug Designation (ODD) & Orphan Medicinal Products
- Plant Master File / Drug Master File
- Lifecycle /Post Approval Management
- Pharmacovigilance (PV) & Post-Market Surveillance (PMS)